SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yen Ying Lim, Victor L. Villemagne, Robert H. Pietrzak, David Ames, Kathryn A. Ellis, Karra Harrington, Peter J. Snyder, Ralph N. Martins, Colin L. Masters, Christopher C. Rowe, Paul Maruff, APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease, Neurobiology of Aging, 2015, 36, 3, 1239

    CrossRef

  2. 2
    Kevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, Fiona Lamb, Narelle Langdon, Ana M Catafau, Andrew W Stephens, John Seibyl, Ludger M Dinkelborg, Cornelia B Reininger, Barbara Putz, Beate Rohde, Colin L Masters, Christopher C Rowe, Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study, Journal of Neurology, Neurosurgery & Psychiatry, 2015, 86, 4, 431

    CrossRef

  3. 3
    Yen Ying Lim, Paul Maruff, Rachel Schindler, Brian R. Ott, Stephen Salloway, Don C. Yoo, Richard B. Noto, Cláudia Y. Santos, Peter J. Snyder, Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease, Neurobiology of Aging, 2015,

    CrossRef

  4. 4
    Christiane Reitz, Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities, Expert Review of Molecular Diagnostics, 2015, 15, 3, 339

    CrossRef

  5. 5
    Kirk A. Frey, Myria Petrou, Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes, Clinical and Translational Imaging, 2015, 3, 1, 57

    CrossRef

  6. 6
    Benjamin M. Kandel, Brian B. Avants, James C. Gee, Steven E. Arnold, David A. Wolk, Andrew Saykin, Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment, Journal of Alzheimer's Disease, 2015, 46, 4, 901

    CrossRef

  7. 7
    Ugo Paolo Guerra, Flavio Mariano Nobili, Alessandro Padovani, Daniela Perani, Alberto Pupi, Sandro Sorbi, Marco Trabucchi, Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practice, Neurological Sciences, 2015, 36, 6, 1075

    CrossRef

  8. 8
    Johannes Brettschneider, Kelly Del Tredici, Virginia M.-Y. Lee, John Q. Trojanowski, Spreading of pathology in neurodegenerative diseases: a focus on human studies, Nature Reviews Neuroscience, 2015, 16, 2, 109

    CrossRef

  9. 9
    Henryk Barthel, John Seibyl, Osama Sabri, The role of positron emission tomography imaging in understanding Alzheimer’s disease, Expert Review of Neurotherapeutics, 2015, 15, 4, 395

    CrossRef

  10. 10
    James A. Hendrix, Brad Finger, Michael W. Weiner, Giovanni B. Frisoni, Takeshi Iwatsubo, Christopher C. Rowe, Seong Yoon Kim, Salvador M. Guinjoan, Gustavo Sevlever, Maria C. Carrillo, The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update, Alzheimer's & Dementia, 2015, 11, 7, 850

    CrossRef

  11. 11
    Robert H. Pietrzak, Yen Ying Lim, David Ames, Karra Harrington, Carolina Restrepo, Ralph N. Martins, Alan Rembach, Simon M. Laws, Colin L. Masters, Victor L. Villemagne, Christopher C. Rowe, Paul Maruff, Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing, Neurobiology of Aging, 2015, 36, 3, 1231

    CrossRef

  12. 12
    Jacob G. Dubroff, Ilya M. Nasrallah, Will PET Amyloid Imaging Lead to Overdiagnosis of Alzheimer Dementia?, Academic Radiology, 2015, 22, 8, 988

    CrossRef

  13. 13
    Y Y Lim, V L Villemagne, S M Laws, R H Pietrzak, P J Snyder, D Ames, K A Ellis, K Harrington, A Rembach, R N Martins, C C Rowe, C L Masters, P Maruff, APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease, Molecular Psychiatry, 2014,

    CrossRef

  14. 14
    Piers Johnson, Luke Vandewater, William Wilson, Paul Maruff, Greg Savage, Petra Graham, Lance S Macaulay, Kathryn A Ellis, Cassandra Szoeke, Ralph N Martins, Christopher C Rowe, Colin L Masters, David Ames, Ping Zhang, Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease, BMC Bioinformatics, 2014, 15, Suppl 16, S11

    CrossRef

  15. 15
    Victor L Villemagne, Seong Yoon Kim, Christopher C Rowe, Takeshi Iwatsubo, Imago Mundi, Imago AD, Imago ADNI, Alzheimer's Research & Therapy, 2014, 6, 5-8

    CrossRef

  16. 16
    F. Jessen, R. Dodel, Prädiktion der Alzheimer-Demenz, Der Nervenarzt, 2014, 85, 10, 1233

    CrossRef

  17. 17
    Yan Ma, Shuo Zhang, Jing Li, Dong-Ming Zheng, Yang Guo, Juan Feng, Wei-Dong Ren, Predictive Accuracy of Amyloid Imaging for Progression From Mild Cognitive Impairment to Alzheimer Disease With Different Lengths of Follow-up, Medicine, 2014, 93, 27, e150

    CrossRef

  18. 18
    L Cheng, J D Doecke, R A Sharples, V L Villemagne, C J Fowler, A Rembach, R N Martins, C C Rowe, S L Macaulay, C L Masters, A F Hill, Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment, Molecular Psychiatry, 2014,

    CrossRef

  19. 19
    Reisa Sperling, Elizabeth Mormino, Keith Johnson, The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials, Neuron, 2014, 84, 3, 608

    CrossRef

  20. 20
    Rik Vandenberghe, The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia, Current Neurology and Neuroscience Reports, 2014, 14, 11

    CrossRef

  21. 21
    Elizabeth C. Mormino, The Relevance of Beta-Amyloid on Markers of Alzheimer’s Disease in Clinically Normal Individuals and Factors That Influence These Associations, Neuropsychology Review, 2014, 24, 3, 300

    CrossRef